Search research articles
Contact Us
Filters
Showing results (701-710 of 819) with videos related to
Page
of 82
Sort By:
The Journal of Clinical Investigation
|
June 29, 2018
ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiation
Frank P Vendetti, Pooja Karukonda, David A Clump, et al.
Oral Oncology
|
April 18, 2016
Corrigendum to "Cetuximab activity in dysplastic lesions of the upper aerodigestive tract" [Oral Oncol. 53 (2016) 60-66]
Zubair Khan, Joel B Epstein, Shanthi Marur, et al.
Ophthalmology Science
|
February 5, 2024
Imaging Modalities for Assessing the Vascular Component of Diabetic Retinal Disease: Review and Consensus for an Updated Staging System
Tien-En Tan, Lee M Jampol, Frederick L Ferris, et al.
International Journal of Radiation Biology
|
February 20, 2020
Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpoints
Jessica M Molkentine, David P Molkentine, Kathleen A Bridges, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 27, 2019
Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use
Robert L Ferris, Lisa Licitra, Jerome Fayette, et al.
Head & Neck
|
April 10, 2024
International guidelines for intratumoral and intranodal injection of NBTXR3 nanoparticles in head and neck cancers
Xavier Liem, Thierry de Baère, Omar I Vivar, et al.
Head & Neck
|
February 6, 2021
Characterizing postoperative physiologic swallow function following transoral robotic surgery for early stage tonsil, base of tongue, and unknown primary human papillomavirus-associated squamous cell carcinoma
Lauren Ottenstein, Hannah Cornett, Jeffrey M Switchenko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2016
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group
Shanthi Marur, Shuli Li, Anthony J Cmelak, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
July 31, 2015
Early Oral Tongue Squamous Cell Carcinoma: Sampling of Margins From Tumor Bed and Worse Local Control
Jessica H Maxwell, Lester D R Thompson, Margaret S Brandwein-Gensler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2022
Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer
Robert L Ferris, Jessica Moskovitz, Sheryl Kunning, et al.
Page
of 82
Search research articles
Search
Showing results (701-710 of 819) with videos related to
Sort By:
Page
of 82
The Journal of Clinical Investigation
|
June 29, 2018
ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiation
Frank P Vendetti, Pooja Karukonda, David A Clump, et al.
Oral Oncology
|
April 18, 2016
Corrigendum to "Cetuximab activity in dysplastic lesions of the upper aerodigestive tract" [Oral Oncol. 53 (2016) 60-66]
Zubair Khan, Joel B Epstein, Shanthi Marur, et al.
Ophthalmology Science
|
February 5, 2024
Imaging Modalities for Assessing the Vascular Component of Diabetic Retinal Disease: Review and Consensus for an Updated Staging System
Tien-En Tan, Lee M Jampol, Frederick L Ferris, et al.
International Journal of Radiation Biology
|
February 20, 2020
Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpoints
Jessica M Molkentine, David P Molkentine, Kathleen A Bridges, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 27, 2019
Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use
Robert L Ferris, Lisa Licitra, Jerome Fayette, et al.
Head & Neck
|
April 10, 2024
International guidelines for intratumoral and intranodal injection of NBTXR3 nanoparticles in head and neck cancers
Xavier Liem, Thierry de Baère, Omar I Vivar, et al.
Head & Neck
|
February 6, 2021
Characterizing postoperative physiologic swallow function following transoral robotic surgery for early stage tonsil, base of tongue, and unknown primary human papillomavirus-associated squamous cell carcinoma
Lauren Ottenstein, Hannah Cornett, Jeffrey M Switchenko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2016
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group
Shanthi Marur, Shuli Li, Anthony J Cmelak, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
July 31, 2015
Early Oral Tongue Squamous Cell Carcinoma: Sampling of Margins From Tumor Bed and Worse Local Control
Jessica H Maxwell, Lester D R Thompson, Margaret S Brandwein-Gensler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2022
Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer
Robert L Ferris, Jessica Moskovitz, Sheryl Kunning, et al.
Page
of 82